Determine the necessary mass, volume, or concentration for preparing a solution.
This is a demo store. No orders will be fulfilled.
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
A755865-1g | 1g | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $112.90 | |
A755865-5g | 5g | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $315.90 | |
A755865-10g | 10g | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $581.90 |
Specifications & Purity | BioReagent, ≥99%(HPLC), from microbial |
---|---|
Biochemical and Physiological Mechanisms | P2 purinergic agonist; increases activity of Ca2+-activated K+ channels; substrate for ATP-dependent enzyme systems |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Grade | BioReagent |
Product Description | Adenosine 5γ-triphosphate (ATP) is a central component of energy storage and metabolism in vivo. ATP is use in many cellular processes, respiration, biosynthetic reactions, motility, and cell division. ATP is a substrate of many kinases involved in cell signaling and of adenylate cyclase(s) that produce the second messenger cAMP. ATP provides the metabolic energy to drive metabolic pumps. ATP serves as a coenzyme in a wide array of enzymatic reactions. |
IUPAC Name | disodium;[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-oxidophosphoryl] hydrogen phosphate;hydrate |
---|---|
INCHI | InChI=1S/C10H16N5O13P3.2Na.H2O/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(26-10)1-25-30(21,22)28-31(23,24)27-29(18,19)20;;;/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H,23,24)(H2,11,12,13)(H2,18,19,20);;;1H2/q;2*+1;/p-2/t4-,6-,7-,10-;;;/m1.../s1 |
InChi Key | NTBQNWBHIXNPRU-MSQVLRTGSA-L |
Canonical SMILES | C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)COP(=O)(O)OP(=O)([O-])OP(=O)(O)[O-])O)O)N.O.[Na+].[Na+] |
Isomeric SMILES | C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)([O-])OP(=O)(O)[O-])O)O)N.O.[Na+].[Na+] |
WGK Germany | 3 |
Alternate CAS | 987-65-5 |
PubChem CID | 16218877 |
Molecular Weight | 551.14(anhydrous basis) |
Solubility | H 2 O: 50 mg/mL, clear, colorless |
---|---|
Specific Rotation[α] | -19° (C=3,H2O) |
Molecular Weight | 569.160 g/mol |
XLogP3 | |
Hydrogen Bond Donor Count | 6 |
Hydrogen Bond Acceptor Count | 18 |
Rotatable Bond Count | 8 |
Exact Mass | 568.97 Da |
Monoisotopic Mass | 568.97 Da |
Topological Polar Surface Area | 286.000 Ų |
Heavy Atom Count | 34 |
Formal Charge | 0 |
Complexity | 789.000 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 4 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
The total count of all stereochemical bonds | 0 |
Covalently-Bonded Unit Count | 4 |
WGK Germany | 3 |
---|---|
Merck Index | 155 |
1. Ziliang He, Yeye Hu, Ying Zhang, Jing Xie, Zhiqiang Niu, Guigui Yang, Ji Zhang, Zixuan Zhao, Shuai Wei, Haifeng Wu, Weicheng Hu. (2024) Asiaticoside exerts neuroprotection through targeting NLRP3 inflammasome activation. PHYTOMEDICINE, 127 (155494). [PMID:38471370] [10.1016/j.phymed.2024.155494] |
2. Wang Hao, Zhuang Hui, Tang Wenjing, Zhu Jun, Zhu Wei, Jiang Lingxiang. (2024) Coacervate-pore complexes for selective molecular transport and dynamic reconfiguration. Nature Communications, 15 (1): (1-14). [PMID:39567561] [10.1038/s41467-024-54510-9] |
3. Yi Duan, Mengqiong Deng, Bin Liu, Xianwei Meng, Jinghan Liao, Yijie Qiu, Zhihua Wu, Jiangtao Lin, Yi Dong, Yourong Duan, Ying Sun. (2024) Mitochondria targeted drug delivery system overcoming drug resistance in intrahepatic cholangiocarcinoma by reprogramming lipid metabolism. BIOMATERIALS, 309 (122609). [PMID:38754290] [10.1016/j.biomaterials.2024.122609] |
4. Ya-Ling Chen, Yi Wang, Qiu-Yu Fang, Tong Wang, Cong Chen, Tong-Yao Gao, Ming Wu, Wei-Ping Zhang, Yun-Bi Lu. (2024) PARP-1 inhibitor alleviates cerebral ischemia/reperfusion injury by reducing PARylation of HK-1 and LDH in mice. EUROPEAN JOURNAL OF PHARMACOLOGY, 967 (176377). [PMID:38346469] [10.1016/j.ejphar.2024.176377] |
1. Ziliang He, Yeye Hu, Ying Zhang, Jing Xie, Zhiqiang Niu, Guigui Yang, Ji Zhang, Zixuan Zhao, Shuai Wei, Haifeng Wu, Weicheng Hu. (2024) Asiaticoside exerts neuroprotection through targeting NLRP3 inflammasome activation. PHYTOMEDICINE, 127 (155494). [PMID:38471370] [10.1016/j.phymed.2024.155494] |
2. Wang Hao, Zhuang Hui, Tang Wenjing, Zhu Jun, Zhu Wei, Jiang Lingxiang. (2024) Coacervate-pore complexes for selective molecular transport and dynamic reconfiguration. Nature Communications, 15 (1): (1-14). [PMID:39567561] [10.1038/s41467-024-54510-9] |
3. Yi Duan, Mengqiong Deng, Bin Liu, Xianwei Meng, Jinghan Liao, Yijie Qiu, Zhihua Wu, Jiangtao Lin, Yi Dong, Yourong Duan, Ying Sun. (2024) Mitochondria targeted drug delivery system overcoming drug resistance in intrahepatic cholangiocarcinoma by reprogramming lipid metabolism. BIOMATERIALS, 309 (122609). [PMID:38754290] [10.1016/j.biomaterials.2024.122609] |
4. Ya-Ling Chen, Yi Wang, Qiu-Yu Fang, Tong Wang, Cong Chen, Tong-Yao Gao, Ming Wu, Wei-Ping Zhang, Yun-Bi Lu. (2024) PARP-1 inhibitor alleviates cerebral ischemia/reperfusion injury by reducing PARylation of HK-1 and LDH in mice. EUROPEAN JOURNAL OF PHARMACOLOGY, 967 (176377). [PMID:38346469] [10.1016/j.ejphar.2024.176377] |